Volume 11
Prognostic Factor and Serum Biomarker Changes in Non-Surgical Hepatocellular Carcinoma Patients Treated with Radioembolization
1. Abstract
1.1: Background
Transarterial radioembolization (TARE) with 90Y is a primary therapy for hepatocellular carcinoma (HCC), including patients
with portal vein thrombosis (PVT). Patient survival subgroups post TARE have not been clearly defined.
Surgical Management in Sacrococcygeal Pilonidal Sinus Disease Depending on The Suggested Staging System
1. Abstract
1.1. Background
The optimal treatment for the sacrococcygeal pilonidal disease has not been established. Recurrence rates vary by surgical technique.
Recurrence wasn’t the only factor in choosing the optimal technique. The procedure should be easy, inexpensive, have few com plications, and allow the patient to return to work or routine
Herpes Zoster Mimmicking Renal Colic
1. Abstract
1.1. Back Ground
Herpes zoster, or shingles, is a painful viral infection caused by the reactivation of the varicella-zoster virus (VZV), the same virus as
chickenpox, resulting in a blistering rash, often on one side of the body or face, accompanied by burning pain, tingling, and itching.
Renal Involvement in Inflammatory Bowel Disease: A Two-Center Retrospective Study
1. Abstract
1.1. Introduction and Background
Renal involvement represents a rare but serious complication of inflammatory bowel diseases (IBD).
Outcomes of a PBM-Aligned Single-Unit Platelet Transfusion Policy in Severe UGI Bleeding
1. Abstract
1.1. Introduction
Platelet transfusion practices in patients with upper gastrointestinal (UGI) bleeding have traditionally varied, with limited consensus
on optimal dosing or thresholds especially for severe cases. Our institution implemented a restrictive, single-unit platelet transfusion policy as part of a broader patient blood management (PBM) initiative.
Carcinoma Stomach with HCV- An Uncommon Association
1. Abstract
1.1. Introduction
Hepatitis C Virus (HCV) infection is strongly linked to hepatocellular carcinoma (H.C.C) and also associated with an increased risk
of gastric carcinoma, although the connection to stomach cancer is debated, with some studies showing higher risk.
Liver Transplantation and Survival in Hepatocellular Carcinoma and Viral Hepati tis: A 19-Year Nationwide Cohort from Taiwan
1. Abstract
1.1. Background
Liver transplantation (LT) is the definitive therapy for end-stage liver disease and hepatocellular carcinoma (HCC). However, in
HBV-endemic regions, the allocation-relevant implications of the viral hepatitis status, waiting time, age, and donor type remain in completely defined in real-world transplant systems.
